NIH Funding Announcements

Syndicate content
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 14 hours 48 min ago

Human Studies to Evaluate Promising Medications to Treat Alcohol Use Disorder (R21 Clinical Trial Required)

Mon, 11/06/2017 - 10:49
Funding Opportunity PA-18-197 from the NIH Guide for Grants and Contracts. The objective of this Funding Opportunity Announcement (FOA) is to encourage applications that use human laboratory paradigms and/or clinical trials to evaluate the safety and efficacy of novel or re-purposed compounds, that bind to new targets, for treatment of alcohol use disorder (AUD) or AUD with a comorbid post-traumatic stress disorder.
Categories: NIH-Funding

Applying Metabolomics to Drive Biomarker Discovery in Symptom Science (R21 Clinical Trial Optional)

Mon, 11/06/2017 - 10:47
Funding Opportunity PA-18-158 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement is to encourage applications on biomarker discovery that utilize metabolomics approaches to advance the understanding, assessment and management of symptoms.
Categories: NIH-Funding

End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R21 Clinical Trial Optional)

Mon, 11/06/2017 - 10:46
Funding Opportunity PA-18-155 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to foster research on the unique perspectives, needs, wishes, and decision-making processes of adolescents and young adults (AYA; defined by the World Health Organization and the Centers for Disease Control and Prevention as youth between 12 24 years of age) with serious, advanced illnesses; and research focused on specific end-of-life/palliative care (EOLPC) models that support the physical, psychological, spiritual, and social needs of AYA with serious illness, their families and caregivers.
Categories: NIH-Funding

Applying Metabolomics to Drive Biomarker Discovery in Symptom Science (R01 Clinical Trial Optional)

Mon, 11/06/2017 - 10:43
Funding Opportunity PA-18-140 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement is to encourage applications on biomarker discovery that utilize metabolomics approaches to advance the understanding, assessment and management of symptoms.
Categories: NIH-Funding

End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R01 Clinical Trial Optional)

Mon, 11/06/2017 - 10:34
Funding Opportunity PA-18-137 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to foster research on the unique perspectives, needs, wishes, and decision-making processes of adolescents and young adults (AYA; defined by the World Health Organization and the Centers for Disease Control and Prevention as youth between 12 24 years of age) with serious, advanced illnesses; and research focused on specific end-of-life/palliative care (EOLPC) models that support the physical, psychological, spiritual, and social needs of AYA with serious illness, their families and caregivers.
Categories: NIH-Funding

Alcohol Use Disorders: Behavioral Treatment, Services and Recovery Research (R21 Clinical Trial Optional)

Mon, 11/06/2017 - 10:32
Funding Opportunity PA-18-202 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages grant applications from institutions/organizations that propose to support research on behavioral treatment for alcohol use disorders; organizational, financial, and management factors that facilitate or inhibit the delivery of services for alcohol use disorders; and phenomenon of recovery from alcohol use disorders.
Categories: NIH-Funding

Alcohol Use Disorders: Behavioral Treatment, Services and Recovery Research (R03 Clinical Trial Optional)

Mon, 11/06/2017 - 10:31
Funding Opportunity PA-18-201 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages grant applications from institutions/organizations that propose to support research on behavioral treatment for alcohol use disorders; organizational, financial, and management factors that facilitate or inhibit the delivery of services for alcohol use disorders; and phenomenon of recovery from alcohol use disorders.
Categories: NIH-Funding

Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R03 Clinical Trial Optional)

Mon, 11/06/2017 - 10:29
Funding Opportunity PA-18-200 from the NIH Guide for Grants and Contracts. The objective of this Funding Opportunity Announcement (FOA) is to encourage research on screening and brief interventions to prevent and/or reduce alcohol use and alcohol-related harms among underage and young adult populations.
Categories: NIH-Funding

Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R21 Clinical Trial Optional)

Mon, 11/06/2017 - 10:20
Funding Opportunity PA-18-199 from the NIH Guide for Grants and Contracts. The objective of this Funding Opportunity Announcement (FOA) is to encourage research on screening and brief interventions to prevent and/or reduce alcohol use and alcohol-related harms among underage and young adult populations.
Categories: NIH-Funding

Alcohol Use Disorders: Behavioral Treatment, Services and Recovery Research (R01 Clinical Trial Optional)

Mon, 11/06/2017 - 10:18
Funding Opportunity PA-18-194 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages grant applications from institutions/organizations that propose to support research on behavioral treatment for alcohol use disorders; organizational, financial, and management factors that facilitate or inhibit the delivery of services for alcohol use disorders; and phenomenon of recovery from alcohol use disorders.
Categories: NIH-Funding

Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R01 Clinical Trial Optional)

Mon, 11/06/2017 - 10:17
Funding Opportunity PA-18-193 from the NIH Guide for Grants and Contracts. The objective of this Funding Opportunity Announcement (FOA) is to encourage research on screening and brief interventions to prevent and/or reduce alcohol use and alcohol-related harms among underage and young adult populations.
Categories: NIH-Funding

Human Studies to Evaluate Promising Medications to Treat Alcohol Use Disorder (R01 Clinical Trial Required)

Mon, 11/06/2017 - 10:15
Funding Opportunity PA-18-192 from the NIH Guide for Grants and Contracts. The objective of this Funding Opportunity Announcement (FOA) is to encourage applications that use human laboratory paradigms and/or clinical trials to evaluate the safety and efficacy of novel or re-purposed compounds, that bind to new targets, for treatment of alcohol use disorder (AUD) or AUD with a comorbid post-traumatic stress disorder.
Categories: NIH-Funding

Multidisciplinary Research in Vulvodynia (R21 Clinical Trial Optional)

Mon, 11/06/2017 - 10:13
Funding Opportunity PA-18-096 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to indicate a continued interest in the topic area of vulvodynia or chronic vulvar pain of unknown etiology as an integral area of branch research.This announcement is intended to encourage new research applications in the exploration of etiology, prevention, diagnosis, and therapeutics in the field of vulvodynia. Applications utilizing multidisciplinary approaches and interdisciplinary investigative teams are of particular interest to advance this research agenda.
Categories: NIH-Funding

Multidisciplinary Research in Vulvodynia (R01 Clinical Trial Optional)

Mon, 11/06/2017 - 10:02
Funding Opportunity PA-18-089 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to indicate a continued interest in the topic area of vulvodynia or chronic vulvar pain of unknown etiology as an integral area of branch research.This announcement is intended to encourage new research applications in the exploration of etiology, prevention, diagnosis, and therapeutics in the field of vulvodynia. Applications utilizing multidisciplinary approaches and interdisciplinary investigative teams are of particular interest to advance this research agenda.
Categories: NIH-Funding

The Health of Sexual and Gender Minority (SGM) Populations (R03 Clinical Trial Optional)

Mon, 11/06/2017 - 09:58
Funding Opportunity PA-18-054 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) is committed to supporting research that will increase scientific understanding of the health status of diverse population groups and thereby improve the effectiveness of health interventions and services for individuals within those groups. Priority is placed on understudied populations distinctive health risk profiles. This funding opportunity announcement (FOA) focuses on sexual and gender minority (SGM) populations, including lesbian, gay, bisexual, transgender, and intersex populations. Basic, social, behavioral, clinical, and services research relevant to the missions of the sponsoring Institutes and Centers may be proposed.
Categories: NIH-Funding

The Health of Sexual and Gender Minority (SGM) Populations (R21 Clinical Trial Optional)

Mon, 11/06/2017 - 09:54
Funding Opportunity PA-18-040 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) is committed to supporting research that will increase scientific understanding of the health status of diverse population groups and thereby improve the effectiveness of health interventions and services for individuals within those groups. Priority is placed on understudied populations with distinctive health risk profiles. This funding opportunity announcement (FOA) focuses on sexual and gender minority (SGM) populations, including lesbian, gay, bisexual, transgender, and intersex populations. Basic, social, behavioral, clinical, and services research relevant to the missions of the sponsoring Institutes and Centers may be proposed.
Categories: NIH-Funding

The Health of Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional)

Mon, 11/06/2017 - 09:52
Funding Opportunity PA-18-037 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) is committed to supporting research that will increase scientific understanding of the health status of diverse population groups and thereby improve the effectiveness of health interventions and services for individuals within those groups. Priority is placed on understudied populations with distinctive health risk profiles. This funding opportunity announcement (FOA) focuses on sexual and gender minority (SGM) populations, including lesbian, gay, bisexual, transgender, and intersex populations. Basic, social, behavioral, clinical, and services research relevant to the missions of the sponsoring Institutes and Centers may be proposed.
Categories: NIH-Funding

Research on Informal and Formal Caregiving for Alzheimer's Disease (R01 Clinical Trial Optional)

Mon, 11/06/2017 - 09:50
Funding Opportunity PAR-18-027 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for basic and translational research on caregiving for individuals with Alzheimers disease (AD), at the individual, family, community, and population level. The scope of this funding opportunity includes support for applications that propose the following: interventions to reduce caregiver burden and improve patient outcomes across various settings; population- and community-based research on the scope and impact of AD caregiving; improved characterization of informal and formal caregiving and the burden of caregiving across the full spectrum of the disease, including differences amongsocioeconomic, racial/ethnic and geographic sub-populations; and research addressing the unique challenges related to the provision of advanced AD care, including disparities in access to care.
Categories: NIH-Funding

Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R01 Clinical Trial Required)

Mon, 11/06/2017 - 09:48
Funding Opportunity PAR-18-011 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is intended to support clinical trials conducting preliminary evaluation of the safety and efficacy of imaging agents, as well as an assessment of imaging systems, image processing, image-guided planning and/or execution therapy, contrast kinetic modeling, 3-D reconstruction and other quantitative tools. As many such preliminary evaluations are early in development, this FOA will provide investigators with support for pilot (Phase I and II) cancer imaging clinical trials, including patient monitoring and laboratory studies. This FOA supports novel uses of known/standard clinical imaging agents and methods as well as the evaluation of new agents, systems, or methods. The imaging and image-guided intervention (IGI) investigations, if proven successful in these early clinical trials, can then be validated in larger studies through competitive R01 mechanisms, or through clinical trials in the Specialized Programs of Research Excellence (SPOREs), Cancer Centers and/or the NCI's National Clinical Trials Network.
Categories: NIH-Funding

Systems Biology Approaches using Non-Mammalian Laboratory Animals to Uncover Causes of Neurodegeneration that Might Underlie Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)

Mon, 11/06/2017 - 02:09
Funding Opportunity RFA-AG-18-021 from the NIH Guide for Grants and Contracts. The National Institute on Aging is seeking applications on systems biology approaches using non-mammalian laboratory animal models to increase our understanding of the basic biology underpinning neurodegeneration. It is expected that research supported under this FOA will provide new insights into molecular networks that might be involved in causing, amplifying or protecting against neurodegeneration, and that, in turn, might ultimately contribute to Alzheimer's disease or related dementias. Importantly, a major goal of this FOA is to use interaction and regulatory networks produced and analyzed using systems biology to gain these new insights. Because this FOA is directed toward discovery, currently employed genetically modified laboratory animals used to study AD are not required, although they may be used. Because this FOA requires systems biology approaches, data used to build interaction or regulatory networks may also come from humans or other mammals in which AD, related dementias, or aging-related cognitive decline have been observed. This FOA will only support studies using non-mammalian laboratory animal models; studies involving humans or experiments with mammals will not be allowed under this FOA.
Categories: NIH-Funding